Loading clinical trials...
Loading clinical trials...
A Multicenter Study to Determine the Safety and Efficacy of NT-501 Utilizing the Medica Membrane in Macular Telangiectasia Type 2
Conditions
Interventions
NT-501 CNTF Implant
Locations
3
United States
Bay Area Retina Associates, A Medical Group
Walnut Creek, California, United States
Foundation for Vision Research
Grand Rapids, Michigan, United States
Retina Consultants of Texas
Bellaire, Texas, United States
Start Date
March 6, 2025
Primary Completion Date
May 1, 2026
Completion Date
July 24, 2026
Last Updated
July 10, 2025
NCT07342439
NCT06971939
Lead Sponsor
Neurotech Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions